Regeneron Pharmaceuticals Inc (REGN)

Exchange
NASDAQ
Symbol
REGN
Sector
Healthcare
Industry
Biotechnology
Description
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunology, with leading products like Eylea and Dupixent contributing significantly to its growth. With a robust pipeline of innovative therapies in development, Regeneron is committed to advancing scientific research and addressing critical unmet medical needs, solidifying its influential position within the biopharmaceutical sector.
Country
USA

Stock price

At close: February 6, 2026

  • Open
    769.63
  • High
    786.99
  • Low
    764.78
  • Close
    785.51
  • Volume
    671,121

Financial ratios

Sep 30, 2025